It might be of some consolation to hear that you're not the only one reeling from the current financial crisis: plastic surgeons, too, are feeling the pinch of our troubled economy. It seems fewer people are willing to undergo pricey surgical operations to counter the effects of aging, opting instead for Botox or so-called "fillers," like Restylane, which are far less costly and have practically no recovery time. The newest product, touted as the the next Restylane or Juvederm, is Evolence, which the FDA only recently approved. The kicker: Evolence is a collagen product that is extracted from the tendons of a pig. Radar caught up with New York plastic surgeon Dr. Paul Lorenc (above), the man responsible for the initial studies, and by all counts he's pretty excited about the advancement: